Patients with mutations in heme-oxidized IRP2 ubiquitin ligase 1 (HOIL1; official gene name RBCK1), experience a complex immune disorder involving autoinflammation and inflammatory bowel disease-like symptoms, increased susceptibility to bacterial infections, progressive muscular amylopectinosis and myopathy2. This evidence concerns the gene RBCK1 and immune system disorder.